• EVX-04 is successfully expressed and secreted in human cells enabling immune recognition and activation
  • The vaccine antigens drive specific immune responses across different human immune profiles and induce targeted cell-killing
  • Poster presentation at the European Hematology Association (EHA) 2026 Congress, taking place in Stockholm, Sweden